James Paul Lang is Director of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 889 shares of HALO, which is worth approximately $62,256. The most recent transaction as insider was on Jan 02, 2026, when has been sold 889 shares (Restricted Stock Units) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 889
n/a 3M change
n/a 12M change
Total Value Held $62,256

James Paul Lang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2026
BUY
Grant, award, or other acquisition
-
889 Added 50.0%
889 Restricted Stock Units

Also insider at

OPRX
OptimizeRx Corp Healthcare
BIVI
BIOVIE INC. Healthcare
JPL

James Paul Lang

Director
Rochester, MI

Track Institutional and Insider Activities on HALO

Follow HALOZYME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Track Activities on HALO